The effect of metformin on mortality rates and exercise tolerance in patients with heart failure and type 2 diabetes.

Back

ESC Premium Access

The effect of metformin on mortality rates and exercise tolerance in patients with heart failure and type 2 diabetes.

Session: Drug therapy of heart failure

Topic: Pharmacologic therapy

Speaker: Mr A. Retwinski (Lodz, PL)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Mr Arkadiusz Retwinski

Medical University of Lodz, Lodz (Poland)

0 follower

8 more presentations in this session

Are beta-blockers needed in patients after primary prevention implantable cardioverter-defibrillator? A multicenter population-based cohort study.

Speaker: Professor L. Fauchier (Tours, FR)

Non-withdrawal of beta-blockers in acute decompensated chronic and de-novo heart failure is associated with lower in-hospital and 3-months mortality: Findings from the GULF-CARE

Speaker: Assistant Professor C. Abi Khalil (Doha, QA)

Access

Abstract

Beta-blockers, ACE/ARB and MRA at discharge and outcome after hospitalization of heart failure in octogenarians with HFPEF and HFREF: a report from the BIO-HF registry

Speaker: Professor J. De Sutter (Gent, BE)

Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure

Speaker: Doctor R. Wurm (Vienna, AT)

Anti hypertrophic effects of LCZ696 in chronic cardiac pressure overload

Speaker: Mr E. Sjaastad Norden (Oslo, NO)

Access the full session

Drug therapy of heart failure

Speakers: Mr A. Retwinski, Professor L. Fauchier, Assistant Professor C. Abi Khalil, Professor J. De Sutter, Doctor R. Wurm...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources